Biotech companies establish pipelines to land the FDA’s approval for novel drugs eventually — but the process helps to secure funding, too. Here’s how.
Biotech Companies: How Your Pipeline Influences Investors

Biotech companies establish pipelines to land the FDA’s approval for novel drugs eventually — but the process helps to secure funding, too. Here’s how.
From coast to coast, the biotech industry is booming. Here’s a look at the cities helping this space to thrive and why biotech startups flock there.
Update: We’ve released a new whitepaper examining the Biotech industry. We dive into the insurance landscape, funding, legal climate, and how to approach risk management for companies in this sector. You can download the report here! Most life sciences professionals understand the FDA drug-approval process. Or, at least, you are aware of how painstaking it is to
VC funding for life sciences companies has evolved significantly in the past two decades. Here’s what you need to know about financing in the space.
Plenty of biotech and life science startups launched in late-2018. Here’s a list of the top ten making waves in this space.
Plenty of risks are associated with ESOPs. But, how do they impact your current D&O, E&O, or general liability insurance policy. Here’s the scoop.
Commercial insurance endorsements are the secret sauce that enable your company to grow and develop. Here’s what you should know about them.
Our guide to insurance for Biotechnology companies. What risks do Ag-biotech & Biopharma face? What policies do they need?